Buscar
Mostrando ítems 1-10 de 426
The cost of hematopoietic stem cell transplantation in the real world
(Maney Publishing, 2012-04-01)
In Brazil, the majority of the population does not have private health insurance and the government provides universal health care. Our 'Unique Healthcare System' pays for 95% of the 1500 hematopoietic stem cell transplants ...
Hematopoietic stem cell transplantation: clinical use and perspectives
(SOC BIOLGIA CHILE, 2012)
Hematopoietic stem cell transplantation is the accepted therapy of choice for a variety of malignant and non-malignant diseases in children and adults. Initially developed as rescue therapy for a patient with cancer after ...
C reactive protein and procalcitonin levels for the diagnosis of invasive bacterial infections in allogenic hematopoietic stem cell transplantation recipients Proteína C reactiva y procalcitonina como marcadores de infección bacteriana en niños con neutro
(2007)
Background: The main causes of complications of allogenic hematopoietic stem cell transplantation are infections and graft versus host disease. Aim: To assess the predictive value of C reactive protein (CRP) and procalcitonin ...
Immunological correlates of favorable long-term clinical outcome in multiple sclerosis patients after autologous hematopoietic stem cell transplantation
(2016-08-01)
High dose immunosuppression followed by autologous hematopoietic stem cell transplantation (AHSCT) induces prolonged clinical remission in multiple sclerosis (MS) patients. However, how patient immune profiles are associated ...
Novel preparative regimens in hematopoietic stem cell transplantation
(Bentham Science Publ Ltd, 2008-07-01)
Hematopoietic stem cell transplantation is an established treatment modality for malignant and non-malignant diseases. Prior to the infusion of allogeneic or autologous cells, patients usually receive radiation or chemotherapy. ...
Factors affecting hematopoietic progenitor cell mobilization: An analysis of 307 patients
(PERGAMON-ELSEVIER SCIENCE LTD, 2008)
We reviewed the data of 307 patients treated with autologous bone marrow transplantation with the aim to identify factors associated with poor hematopoietic stern cell (HSC) mobilization after administration of cyclophosphamide ...
Antimicrobial therapy in cancer patients and hematopoietic stem cell transplantation receptors Parte iv. Terapia antimicrobiana en pacientes con cáncer y receptores de trasplante de precursores hematopoyéticos
(Sociedad Chilena de Infectologia, 2019)
This manuscript includes the antiinfective therapeutic resources for immunocompromised patients under chemotherapy by cancer or hematopoietic stem cells transplant (HSCT) receptors. The document presents the antimicrobial ...
Intravenous palivizumab in respiratory syncytial virus infection after hematopoietic stem cell transplant in children
(Wiley, 2017)
Respiratory syncytial virus (RSV) infection can cause lower respiratory tract disease and mortality in pediatric hematopoietic stem cell transplant (HSCT) recipients. We report two children who underwent HSCT and developed ...
Evaluation of metabolic syndrome after hematopoietic stem cell transplantation in children and adolescents
(2012)
Background: To determine the prevalence, characteristics, and risk factors associated with metabolic syndrome (MS) in patients undergoing hematopoietic stem cell transplantation (HSCT) in the Chilean National Program. ...
BCL2A1a Over-Expression in Murine Hematopoietic Stem and Progenitor Cells Decreases Apoptosis and Results in Hematopoietic Transformation
(PUBLIC LIBRARY SCIENCESAN FRANCISCO, 2012)
We previously reported the development of a lethal myeloid sarcoma in a non-human primate model utilizing retroviral vectors to genetically modify hematopoietic stem and progenitor cells. This leukemia was characterized ...